Physician profile
Michael N Johnson
NPI 1356352397
$10,697.84
in general payments reported to CMS, 2019-2025
16 companies · $2,273 in 2025
The $2,273 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,871 · 2020: $1,392 · 2021: $955 · 2022: $1,070 · 2023: $1,537 · 2024: $1,599 · 2025: $2,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,402 · Travel and Lodging: $7.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,402.16 |
| Travel and Lodging | $7.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,309.69 | 2019-2025 | Impella |
| Boston Scientific Corporation | $2,109.66 | 2019-2025 | Avvigo Guidance System, Rotapro, Synergy |
| Abbott Laboratories | $1,764.34 | 2019-2025 | Optis, Navitor |
| Medtronic, INC. | $1,246.69 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Ffrangio |
| Shockwave Medical, INC | $1,002.03 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $493.27 | 2019-2021 | |
| Terumo Medical Corporation | $450.85 | 2019-2022 | |
| Edwards Lifesciences Corporation | $427.58 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia |
| Spectrawave, INC | $369.45 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Medtronic Vascular, INC. | $190.49 | 2020 | |
| Asahi Intecc USA, INC. | $179.00 | 2023 | Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $40.53 | 2023-2024 | Xarelto |
| Philips North America LLC | $35.60 | 2025 | Mcot |
| Novartis Pharmaceuticals Corporation | $33.49 | 2024-2025 | |
| Teleflex LLC | $28.33 | 2024 | Manta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $16.84 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.